In NPC, it activates the NF-κB/STAT3 pathway, upregulates pro-inflammatory factors (e.g., IL-6, IL-10) to induce a tumor-promoting microenvironment, and enhances metastatic potential through the EMT program [126]. The gene discussed is NFKB1; the disease is neoplasm.